The orthotopic liver model, transcriptomic analysis, and HBx-Tg mouse interventions collectively elucidate the role of the HBx/MALAT1/IGF2BP3 axis in HBV-related HCC (Fig. 8). Here, IGF2BP3 is linked to hepatocellular carcinoma.